Fidelity Global Investme...【FCIG】銘柄情報 | ADVFN

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
ETF
カナダ
TSX
Fidelity Global Investment Grade Bond ETF (FCIG) 銘柄情報

Fidelity Global Investment Grade Bond ETF (FCIG)

21.50

0.00

(0.00%)

終了 1月7日 6:12AM

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

21.50

買値

21.43

売値

21.50

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

21.50

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

-

発行済株式数

3,400,000

配当利回り

-

PER

-140.61

1 株当たり利益 (EPS)

-0.15

歳入

-15k

純利益

-520k

セクター

Finance Services

業界

Finance Services

本社

Toronto, Ontario, Can

設立

-

Fidelity Global Investment Grade Bond ETF is listed in the Finance Services sector of the トロント証券取引所 with ticker FCIG. The last closing price for Fidelity Global Investme... was $21.50. Over the last year, Fidelity Global Investme... shares have traded in a share price range of $ 0.00 to $ 0.00.

Fidelity Global Investme... currently has 3,400,000 shares in issue. The market capitalisation of Fidelity Global Investme... is $73.10 million. Fidelity Global Investme... has a price to earnings ratio (PE ratio) of -140.61.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
MSAIMultiSensor AI Holdings Inc	US$ 2.80 (40.00%)	2.54M
MCVTMill City Ventures III Ltd	US$ 3.0201 (33.63%)	98.63k
XTIAXTI Aerospace Inc	US$ 0.1167 (32.61%)	367.95M
QRTEBQurate Retail Inc	US$ 3.13 (22.27%)	103
NARIInari Medical Inc	US$ 78.87 (21.34%)	4.7M
ENVBEnveric Biosciences Inc	US$ 0.34 (-19.53%)	433.75k
GDTCCytoMed Therapeutics Ltd	US$ 2.86 (-16.62%)	63.14k
AMSTAmesite Inc	US$ 3.45 (-14.81%)	60.65k
SLRNACELYRIN Inc	US$ 2.9799 (-14.62%)	506.18k
ACXPAcurx Pharmaceuticals Inc	US$ 0.9401 (-13.75%)	166.45k
XTIAXTI Aerospace Inc	US$ 0.1167 (32.61%)	367.95M
SVMHSRIVARU Holding Ltd	US$ 0.0512 (10.58%)	29.93M
CRKNCrown Electrokinetics Corporation	US$ 0.145 (9.02%)	27.07M
CEROCERo Therapeutics Holdings Inc	US$ 0.0468 (10.64%)	18.45M
CDTConduit Pharmaceuticals Inc	US$ 0.082 (13.42%)	16.67M

La Flaca

La Flaca 3分前

Alot hinges on EMA approval so it makes sense that Anavex is positioning itself for maximum visibility with journal articles, presentations, OLE data presentation. The drug seems to be effective if taken early enough. I hope this is top of mind during EMA approval process. That's the bottom line - t

TheKid5

TheKid5 3分前

$0.00000000000000000000000

dia76ca

dia76ca 3分前

PRIORITY REVIEW (FDA)
"Prior to approval, each drug marketed in the United States must go through a detailed FDA review process. In 1992, under the Prescription Drug User Act (PDUFA), FDA agreed to specific goals for improving the drug review time and created a two-tiered system of review tim

Threes

They probably had buyers in Ampersand in the waiting. Nick getting his ill gotten gains while they consolidate the shares.

ThunderousSeer8

ThunderousSeer8 3分前

There's a lot of human behavior and psychology in investing. I think they can't understand what it's even like to be a person that has a sustainable future regardless of how this turns out. Their perspectives are so limited and their ability to analyze themselves is lacking. I wish you all the best

flipper44

flipper44 3分前

I think the short positions that bought warrants with their initial proceeds, can cover their short shares by exercising an equal number of warrants at a fixed low price. There are 47 million short shares, some of which may be hedged with warrants.

I don’t know enough about timing

DrivenByPain

DrivenByPain 5分前

SGDH Security Details Updated Today No Change 01/06/2025 https://www.otcmarkets.com/stock/SGDH/security

ergo sum

ergo sum 6分前

The democrats gave away the election and now like to pretend how polite they are surrendering power.

looking 4 a win

looking 4 a win 6分前

Great question, pigs don't always get slaughtered. Sometimes they go on to become pig kings!
Anyway, also- foubl?

barnyarddog

barnyarddog 6分前

https://www.stocktitan.net/news/BAYA/

marcis

Yes good post.
Same here, I don’t have to react when I see a pullback.
In fact seeing these guys show up all of a sudden spewing no one knows blah blah blah
It all was in order, which will be soon, the share price will be 1000x current

They do scare half knowledg

chainma1l

chainma1l 6分前

Probably just naked shorties or MM manipulators!
TO DA MOOON!

What an amazing company.
Goo VPER

jmhgolf

jmhgolf 6分前

Trinityz1

Trinityz1 6分前

thx, first time have seen that

badog

I never had the link. I wouldn't open a link by a person who posted for the first time. Homebrew may have it.
Badog

Investor2014

Investor2014 8分前

Yes EMA approval may result in a limited label FDA conditional approval requiring a confirmatory trial that shows dose dependence, is longer and larger with diverse ethnicity.

ThunderousSeer8

ThunderousSeer8 9分前

Yes. I am invested here and in many other markets. I've been here since April of this year. These guys just can't cut it, man. You can see it in the frequency of their posts. They live for this, they absolutely think highly of themselves even though the frequency at which they post shows they haven'

longrider51

longrider51 9分前

Recall and consider the source, right?
This article appeared on National Review (Online) on January 24, 2021.
Note National Review is distinctly a politically right oriented outfit ..
https://mediabiasfactcheck.com/national-review/ .

PickStocks

PickStocks 9分前

Tell everyone again how you are a crypto guru.....did you take advice from the hawk Tuah girl...

SSKILLZ1

SSKILLZ1 9分前

OPTT Was the best performing stock pick today picked by NSOMNIYAK and the Best Top Pick was OPTT picked by NSOMNIYAK. hope this helps.

XMaster2023

XMaster2023 11分前

You missed the point EX. The demand for C-19 vaccines is diminishing. Why is Merck spending 500 mil to increase capacity?
Perhaps they want to help out their Chinese competitors?
Perhaps they need more Vaccine capacity?
Perhaps they already have a deal cut with NWBO and it i

Juststoppingby

Juststoppingby 12分前

It looks like they still need to comply with rule 15c2-11, which took effect not too long ago.

How to Become Quoted on the Pink Market
To be eligible for quotations, companies must:
1. Comply with the requirements of Securities Exchange Act Rule 15c2-11
2. Make cu

Fidelity Global Investme...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約